SCHEMBL5613892

SCHEMBL5613892

CCOC(=O)c1cccc(NC2=NC(=O)C(=Cc3ccc(OCc4ccc(C(F)(F)F)cc4C(F)(F)F)cc3OC)S2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.41
MAPT P10636 4/20 0.41
TP53 P04637 2/20 0.39
POLB P06746 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
CYP1A1 P04798 2/20 0.38
CYP1B1 Q16678 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
UBE2N P61088 1/20 0.38
SYK P43405 1/20 0.38
FOXM1 Q08050 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CDC25B P30305 2/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5613817 0.88 PTPN1 (0.44) PTPN1MAPTCYP1A2CYP3A4CYP2D6
SCHEMBL2200143 0.88 ESRRA (0.47) MAPTPOLBCYP3A4FOXM1MEN1
SCHEMBL2200999 0.88 ESRRA (0.47) MAPTPOLBCYP3A4FOXM1MEN1
SCHEMBL5616853 0.83 FOXM1 (0.45) PTPN1CYP1A1CYP1B1FOXM1MEN1
SCHEMBL5616931 0.82 FOXM1 (0.43) PTPN1CYP1A1CYP1B1FOXM1MEN1
SCHEMBL5613835 0.81 FOXM1 (0.41) PTPN1CYP1A1CYP1B1FOXM1MEN1
SCHEMBL5617115 0.80 ESRRA (0.42) PTPN1CYP1A1CYP1B1FOXM1MEN1
SCHEMBL5613843 0.79 PTPN1 (0.43) PTPN1FOXM1ESRRAALOX5
SCHEMBL8267384 0.79 ESRRA (0.47) MAPTSYKMEN1KMT2ACDC25B
SCHEMBL5614007 0.79 PTPN1 (0.45) PTPN1FOXM1ESRRAMRGPRX4ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805154-A2 PHARMACEUTICAL COMPOSITIONS Exelixis, Inc. (US) 2007-07-11 EP disclosed
WO-2006047269-A2 PHARMACEUTICAL COMPOSITIONS EXELIXIS, INC. (US) 2006-05-04 WO disclosed